TP receptors regulate renal hemodynamics during angiotensin II slow pressor response

American Journal of Physiology - Renal Physiology

Volumn 287, Issue 4 56-4, 2004, Pages

  Kawada, Noritaka ^a   Dennehy, Kathryn ^a   Solis, Glenn ^a   Modlinger, Paul ^a   Hamel, Rebecca ^a   Kawada, Julie T ^a   Aslam, Shakil ^a   Moriyama, Toshiki ^b   Imai, Enyu ^b   Welch, William J ^a   Wilcox, Christopher S ^a,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hypertension; Isoprostane; Renal vascular resistance; Thromboxane A2 prostaglandin H2 receptor

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THROMBOXANE A2 RECEPTOR; THROMBOXANE B2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ELECTROLYTE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HEMATOCRIT; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY MASS; KIDNEY VASCULAR RESISTANCE; KNOCKOUT MOUSE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; WILD TYPE;

EID: 4644256807     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00423.2003     Document Type: Article

References (44)

1. 2-receptor-null mice. Hypertension 42: 600-604, 2003.
2. Abe T, Takeuchi K, Takahashi N, Tsutsumi E, Taniyama Y, and Abe K. Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization. J Clin Invest 96: 657-664, 1995.
3. Arendshorst WJ, Brannstrom K, and Ruan X. Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 10: S149-S161, 1999.
4. Arima S, Ren Y, and Juncos LA. Glomerular prostaglandins modulate vascular reactivity of the downstream efferent arterioles. Kidney Int 45: 650-658, 1994.
5. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, and Wilcox CS. Effects of ANG II type I and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003.
6. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, and Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the kidney. Hypertension 39: 269-274, 2002.
7. 1A) angiotensin receptor. Semin Nephrol 17: 404-411, 1997.
8. Deng X, Welch WJ, and Wilcox CS. Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics. Hypertension 27: 1173-1179, 1996.
9. Escalante B, Omata K, Sessa W, Lee SG, Falck JR, and Schwartzman ML. 20-Hydroxyeicosatetraenoic acid is an endothelium-dependent vasoconstrictor in rabbit arteries. Eur J Pharmacol 235: 1-7, 1993.
10. 2 receptors: comparison to rat platelets. Eur J Pharmacol 227: 71-78, 1992.
11. 2 release. J Pharmacol Exp Ther 258: 669-675, 1991.
12. Francois H, Athirakul K, Mao L, Rockman H, and Coffman TM. Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 43: 364-369, 2004.
13. Galipeau D, Arikawa E, Sekirov I, and McNeill JH. Chronic thromboxane synthase inhibition prevents fructose-induced hypertension. Hypertension 38: 872-876, 2001.
14. 2 receptors. J Lipid Mediat Cell Signal 12: 361-378, 1995.
15. Harrison DG, Cai H, Landmesser U, and Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4: 51-61, 2003.
16. Kawada N, Imai E, Karber A, Welch WJ, and Wilcox CS. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol 13: 2860-2868, 2002.
17. Lin L, Mistry M, Stier CT, and Nasjletti A. Role of prostanoids in renin-dependent and renin-independent hypertension. Hypertension 17: 517-525, 1991.
18. Lin L and Nasjletti A. Role of endothelium-derived prostaglandin in angiotensin-induced vasoconstriction. Hypertension 18: 158-164, 1991.
19. Luft FC, Wilcox CS, Unger T, Kuhn R, Demmert G, Rohmeiss P, Ganten D, and Sterzel RB. Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins. Hypertension 14: 396-403, 1989.
20. Mistry M, Muirhead EE, Yamaguchi Y, and Nasjletti A. Renal function in rats with angiotensin II-salt-induced hypertension: effect of thromboxane synthesis inhibition and receptor blockade. J Hypertens 8: 75-83, 1990.
21. Mistry M and Nasjletti A. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension. Hypertension 11: 758-762, 1990.
22. Mistry M and Nasjletti A. Contrasting effect of thromboxane synthase inhibitors and a thromboxane receptor antagonist on the development of angiotensin II-salt-induced hypertension in rats. J Pharmacol Exp Ther 253: 90-94, 1990.
23. Navar LG. Integrating multiple paracrine regulators of renal microvascular dynamics. Am J Physiol Renal Physiol 274: F433-F444, 1998.
24. Navar LG, Ichihara A, Chin SY, and Imig JD. Nitric oxide-angiotensin II interactions in angiotensin II-dependent hypertension. Acta Physiol Scand 168: 139-147, 2000.
25. Ren Y, Garvin JL, Falck JR, Renduchintala KV, and Carretero OA. Glomerular autacoids stimulated by bradykinin regulate efferent arteriole tone. Kidney Int 63: 987-993, 2003.
26. - and NO. Am J Physiol Renal Physiol 279: F302-F308, 2000.
27. 2. Hypertension 33: 424-428, 1999.
28. Schnermann J, Traynor T, Pohl H, Thomas DW, Coffman TM, and Briggs JP. Vasoconstrictor responses in thromboxane receptor knockout mice: tubuloglomerular feedback and ureteral obstruction. Acta Physiol Scand 168: 201-207, 2000.
29. Schwartzman ML, Falck JR, Yadagiri P, and Escalante B. Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase: formation and identification of novel endothelium-dependent vasoconstrictor metabolites. J Biol Chem 264: 11658-11662, 1989.
30. 2) angiotensin receptor. Proc Natl Acad Sci USA 96: 6506-6510, 1999.
31. Stevenson KM, Edgley AJ, Bergstrom G, Worthy K, Kett MM, and Anderson WP. Angiotensin II infused intrarenally causes preglomerular vascular changes and hypertension. Hypertension 36: 839-844, 2000.
32. Takahashi N, Takeuchi K, Abe T, Sugawara A, and Abe K. Immunolocalization of rat thromboxane receptor in the kidney. Endocrinology 137: 5170-5173, 1996.
33. 2. J Clin Invest 102: 1994-2001, 1998.
34. Wang D, Chabrashvili T, and Wilcox CS. Enhanced contractibility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptor, and endothelium. Circ Res 94: 1436-1442, 2004.
35. Wang D, Chen Y, Chabrashvili T, Aslam S, Borrego Conde LJ, Umans JG, and Wilcox CS. Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J Am Soc Nephrol 14: 2783-2789, 2003.
36. 1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney. Hypertension 41: 692-696, 2003.
37. Welch WJ and Wilcox CS. Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic. Role of macula densa. J Clin Invest 89: 1857-1865, 1992.
38. 1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int 59: 1257-1263, 2001.
39. Welch WJ, Wilcox CS, and Dunbar KR. Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic. Am J Physiol Renal Fluid Electrolyte Physiol 257: F554-F560, 1989.
40. 2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat. Am J Physiol Regul Integr Comp Physiol 271: R891-R896, 1996.
41. Wilcox CS, Folger WH, and Welch WJ. Renal vasoconstriction with U-46,619; role of arachidonate metabolites. J Am Soc Nephrol 5: 1120-1124, 1994.
42. Wilcox CS and Lin L. Vasoconstrictor prostaglandins in angiotensin-dependent and renovascular hypertension. J Nephrol 6: 124-133, 1993.
43. Wilcox CS, Welch WJ, and Snellen H. Thromboxane mediates renal hemodynamic response to infused angiotensin II. Kidney Int 40: 1090-1097, 1991.
44. 2 receptors. J Pharmacol Exp Ther 263: 905-909, 1992.